Article
TREM2 and the neuroimmunology of Alzheimer's disease.
Biochemical pharmacology - 15 Apr 2014
Hickman Suzanne E, El Khoury Joseph
Abstract excerpt
Late-onset Alzheimer's disease (AD) is a sporadic disorder with increasing prevalence in aging. The ɛ4 allele of Apolipoprotein E(ApoEɛ4) was the only known major risk factor for late onset AD. Recently, two groups of investigators independently identified variants of the TREM2 gene, encoding triggering receptor expressed on myeloid cells 2 as causing increased susceptibility to late onset AD with an odds ratio...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
